Biotech Values

[swampboots]

MRNA: a ADC platform house:
"Traditional ADCs are a class of cancer biotherapeutics that combine the targeting capabilities of monoclonal antibodies with the cancer-killing ability of cytotoxic drug payloads. Antibodies and payloads are chemically linked, allowing specific drug delivery to cancer cells targeted by the antibody."

Bloomberg did a big peak on the radio this hour,, see CEO bought in June in 3's now 8's......bottom line: insider purchases may
correspond to a bias forecasting UP.